logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Chenyang Duan

The Second Affiliated Hospital of Chongqing Medical University
H指数:23
被引数:1,773

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

362 Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)

362 乌帕替尼在成人和青少年重度斑秃患者中的疗效、安全性和耐受性：来自随机、安慰剂对照、双盲III期研究（UP-AA）的结果

Journal of Investigative Dermatology
IF5.7
2025-11-100
PRE
Arash Mostaghimi; Melinda Gooderham; Charles Lynde; Rodney Sinclair; Brett King; Maria Hordinsky; Lidia Rudnicka; Emma Guttman-Yassky; Sebastian Meerwein; Ahmed Soliman; Xianwei Bu; Chenyang Duan; Tianshuang Wu; Henrique Teixeira; Andreas Lazar; Thierry Passeron
Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16

在UnlIMMited IV期随机临床试验中，Risankizumab治疗生殖器或头皮银屑病在第16周时的疗效与安全性

Dermatology and Therapy
IF4.2
2025-10-250
OA
Eingun James Song; Benjamin Ehst; Brad Glick; George Michael Lewitt; Phoebe Rich; Navid Ezra; Jerry Bagel; Toni Anschutz; Brenton Bialik; Chenyang Duan; Doug Ashley; Manish Patel; Greg St. John; Arathi R. Setty; Lindsay Ackerman

研究方向

暂未获取到该数据
L
Liangming Liu
H 指数:30论文数:227被引数:2,779
H
He Huang
H 指数:14论文数:130被引数:864
李
李涛
H 指数:37论文数:282被引数:5,412
D
Dongyao Hou
H 指数:7论文数:20被引数:451
L
Lei Kuang
H 指数:12论文数:23被引数:544
X
Xinming Xiang
H 指数:12论文数:49被引数:833
X
Xue Zeng
H 指数:8论文数:18被引数:488
R
Ruixue Liu
H 指数:27论文数:112被引数:2,448
S
Shuai Hao
H 指数:22论文数:95被引数:1,582
W
Weilong Hong
H 指数:20论文数:51被引数:1,347